BioMarin Pharmaceutical Statistics
NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
55.20-1.02 (-1.81%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioMarin Pharmaceutical by the numbers
BioMarin Pharmaceutical has a market capitalization of $10.69 billion based on 193.57M shares outstanding. Its trailing P/E ratio is 149.2, above the 3-company peer median of 134.2, and its forward P/E is 8.3. The stock trades 13.6% below its 50-day average and 6.0% below its 200-day average.
Average daily trading volume is 2.01M shares, or about $110.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BMRN valuation vs. peer median
| Metric | BMRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.69B | $10.69B | -0% |
| P/E (TTM) | 149.2 | 134.2 | +11% |
| Forward P/E | 8.3 | 27.2 | -69% |
| Avg. volume | 2.01M | 1.61M | +25% |
Peer median across 8 companies: ELAN, MDGL, RDY, PTGX, AXSM, CORT, BBIO, ARWR.
Valuation
- Market cap
- $10.69B
- P/E (TTM)
- 149.19
- Forward P/E
- 8.34
- Price / sales (latest FY)
- 3.32
- EPS (TTM)
- $0.37
- Shares outstanding
- 193.57M
Price and trading
- Previous close
- 56.22
- Open
- 56.10
- Day range
- 54.76 – 56.60
- 52-week range
- 49.26 – 70.98
- 52-week change
- +0.91%
- Beta
- —
- Volume
- 2.08M
- Average volume
- 2.01M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 26, 2026
Additional statistics
- Market Cap
- 10.69B
- Pe
- 149.19
- Forward Pe
- 8.34
- Eps
- 0.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 70.98
- Week52 Low
- 49.26
- Avg Volume
- 2.01M
- Shares Outstanding
- 193.57M
- Ma50
- 63.87
- Ma200
- 58.72
- Earnings Date
- Oct 26, 2026
- Pct From52w High
- -22.23%
- Pct From52w Low
- 12.06%